ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,762Medicare Part D Prescriptions Filled, Including Refills

Rank: 628 out of 2343

$448K Total Retail Price of All Prescriptions

Rank: 793 out of 2343

182 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
44% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 182 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,639 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 368 368 1 8
LEVOTHYROXINE SODIUM 310 305 2 2
LISINOPRIL 302 288 3 3
CITALOPRAM HBR 258 258 4 17
NAMENDA 237 237 5 36
SIMVASTATIN 232 232 6 1
MIRTAZAPINE 223 223 7 41
METOPROLOL TARTRATE 214 210 8 7
FUROSEMIDE 211 211 9 6
OMEPRAZOLE 202 202 10 4
DONEPEZIL HCL 173 173 11 21
GABAPENTIN 170 170 12 16
POLYETHYLENE GLYCOL 3350 145 145 13 54
AMLODIPINE BESYLATE 142 142 14 5
ALENDRONATE SODIUM 136 132 15 28
POTASSIUM CHLORIDE 130 130 16 18
TRAZODONE HCL 125 125 17 53
EVISTA 121 121 18 128
SERTRALINE HCL 107 107 19 20
DIGOXIN 104 104 20 35
FAMOTIDINE 99 99 21 60
HYDRALAZINE HCL 95 95 22 92
QUETIAPINE FUMARATE 94 94 23 77
CLOTRIMAZOLE 84 84 24 388
ATENOLOL 75 75 25 12
HYDROCHLOROTHIAZIDE 72 72 26 11
GLIPIZIDE 72 72 26 56
SINGULAIR 71 68 28 100
FLUTICASONE PROPIONATE 69 69 29 46
BUPROPION HCL SR 68 60 30 221
IPRATROPIUM-ALBUTEROL 68 68 30 99
PAROXETINE HCL 66 66 32 66
CARVEDILOL 66 66 32 27
VESICARE 66 66 32 145
TAMSULOSIN HCL 62 62 35 29
QUINAPRIL HCL 58 58 36 73
METOPROLOL SUCCINATE 57 57 37 14
AZITHROMYCIN 56 56 38 39
OXYBUTYNIN CHLORIDE 55 55 39 169
CEPHALEXIN 54 54 40 111
PRAVASTATIN SODIUM 54 54 40 15
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.